USA - NYSE:CNC - US15135B1017 - Common Stock
The current stock price of CNC is 34.5 USD. In the past month the price decreased by -8.34%. In the past year, price decreased by -42.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.89 | 302.30B | ||
| ELV | ELEVANCE HEALTH INC | 10.21 | 70.52B | ||
| HUM | HUMANA INC | 14.1 | 33.67B | ||
| HQY | HEALTHEQUITY INC | 26.93 | 8.17B | ||
| MOH | MOLINA HEALTHCARE INC | 7.97 | 7.97B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.33B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.89B | ||
| PGNY | PROGYNY INC | 31.24 | 1.58B |
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. The company is headquartered in St. Louis, Missouri and currently employs 60,500 full-time employees. The company went IPO on 2001-12-13. The firm provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
CENTENE CORP
7700 Forsyth Blvd
St. Louis MISSOURI 63105 US
CEO: Michael F. Neidorff
Employees: 60500
Phone: 13147254477
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. The company is headquartered in St. Louis, Missouri and currently employs 60,500 full-time employees. The company went IPO on 2001-12-13. The firm provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
The current stock price of CNC is 34.5 USD. The price decreased by -2.46% in the last trading session.
CNC does not pay a dividend.
CNC has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
CNC stock is listed on the New York Stock Exchange, Inc. exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CNC.
The outstanding short interest for CENTENE CORP (CNC) is 2.8% of its float.
ChartMill assigns a technical rating of 2 / 10 to CNC. When comparing the yearly performance of all stocks, CNC is a bad performer in the overall market: 69.91% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to CNC. CNC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CNC reported a non-GAAP Earnings per Share(EPS) of 4.04. The EPS decreased by -40.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.44% | ||
| ROE | -25.25% | ||
| Debt/Equity | 0.84 |
26 analysts have analysed CNC and the average price target is 37.21 USD. This implies a price increase of 7.85% is expected in the next year compared to the current price of 34.5.
For the next year, analysts expect an EPS growth of -74.3% and a revenue growth 18.44% for CNC